Is Digital Cognitive Behavioral Therapy for Insomnia Accessible for the Deaf Community? Authors: Veronica Van Rossen, Ishana Kapoor, Marleigh Treger, Christopher Miller, Philip Cheng Published: 2026 ABSTRACT AbstractWhile digital cognitive behavioral therapy for insomnia (dCBT-I) is highly effective, accessibility and adherence challenges persist, especially among vulnerable groups. To highlight unaccounted gaps in dCBT-I treatment adherence, a qualitative interview and case study were conducted to explore the experience of a deaf individual engaging in a six-week dCBT-I program. The patient showed strong adherence and improved sleep efficiency from 63% at Session 1 to 87% at Session 6, with feedback highlighting key accessibility barriers (eg, translation of audio content, inaccessible treatment recommendations) and facilitators (eg, telehealth sessions, motivational approach). This case serves as a foundation for future research and innovation, aiming to reduce treatment disparities in the digital mental health sphere.Keywords: access, deaf, single case methods, technology, insomnia, sleep, cognitive behavioral therapy Introduction The risk for developing comorbid physical and mental health conditions is doubled for people with hearing disabilities.1 Insomnia disorder stands out among these comorbidities, with prevalence rates as high as 70% in individuals with hearing disabilities,2,3 which is disproportionately elevated when compared to the general population (10%).4 This is particularly significant as insomnia is linked to deficits in executive functioning and attentional control5 which those with hearing impairments rely heavily on to bridge gaps in communication. Moreover, insomnia is associated with mood disturbances (eg, reduced positive affect, increased anxiety, depression6). Emotional challenges can exacerbate communication difficulties and social isolation in individuals with hearing loss. The additional impact of insomnia on health and daily functioning underscores the urgent need for accessible insomnia treatments within the deaf community. Cognitive Behavioral Treatment for Insomnia (CBT-I) is widely recognized as the first-line treatment for insomnia disorder.7 Unlike hypnotic medications, CBT-I produces durable treatment gains for both insomnia and comorbid disorders such as depression and anxiety.8,9 However, the shortage of trained CBT-I providers poses a significant accessibility barrier.10 Effectively delivering CBT-I—whether in-person or digitally—requires specialized training and thoughtful integration within healthcare systems. This, coupled with inconsistent insurance coverage, leaves providers defaulting to pharmaceutical approaches.11 For individuals with hearing disabilities, this shortage is compounded by extant medical accessibility issues, including a significant shortage of American Sign Language (ASL) interpreters proficient in medical verbiage (50:1 ratio of patients to ASL interpreters).12 Many deaf individuals are underserved due to communication barriers.13 To address barriers of provider accessibility, CBT-I now exists as a digital program that can be implemented without clinician involvement, thus allowing more patients to effectively engage in treatment. This expansion of digital CBT-I (dCBT-I) administration methods aims for increased accessibility and has proven effective in the reduction of insomnia symptoms.14 However, the feasibility of dCBT-I is not well-established for those in the deaf community, as it is unclear how the treatment addresses this population’s specific accessibility needs. Using dCBT-I for people with comorbid hearing impairment and insomnia also eliminates barriers of interpretation with appropriate captioning to digitally relay health information. The intersection of hearing impairment and dCBT-I remains understudied and poorly understood. This is, in part, due to a small portion of Americans experiencing hearing impairments (3.6%)12 and due to the rarity of capturing a deaf patient actively participating in a treatment with many accessibility barriers. Given this landscape, we present a case study as a valuable entry point to explore the real-world experiences of a deaf individual navigating dCBT-I. This case highlights key barriers and facilitators in treatment adherence, providing a foundation for future research. By examining this unique patient journey, it reveals critical gaps in digital treatment accessibility and informs how digital-health interventions can be better designed to meet the needs of the deaf and hard-of-hearing communities.15 Methods The patient is a Hispanic male in middle to late adulthood, of low-socioeconomic status, with a chief complaint of insomnia. He reported being deaf since age 10 associated with prolonged exposure to untreated fever due to a lack of access to health care. He presented with moderate to severe insomnia (Insomnia Severity Index score = 19), predominantly reporting struggling with sleep onset and maintenance. The patient tried multiple treatments for insomnia with limited success; prior medication regimen included Trazodone, Ambien, Ambien CR, Lunesta, Restoril, Temazepam, Mirtazapine, Ativan, and Gabapentin, all of which were ineffective. He reported that medical treatments with a clinical provider have been challenging due to transportation, cost, and the scarcity of ASL translators. Despite these challenges, the patient still expressed a desire for behavioral treatments, which was part of the appeal of participating in a study with a digital and self-paced treatment approach. The larger registered randomized controlled trial includes a dCBT-I intervention which consisted of six sessions and included daily sleep diary tracking, sleep restriction, and sleep hygiene education. The patient was randomized to the experimental condition with nurse coaching provided as a supplemental component. Although the parent study included two arms, the present study focuses on a single participant selected for case analysis to illustrate feasibility, adherence, and response within the experimental condition. The patient successfully completed the dCBT-I program with full adherence to treatment and completed all six sessions without missing any weekly appointments or daily sleep diary entries, indicating a high level of engagement with both the digital platform and coaching support. Sleep outcomes were derived from daily self-reported sleep diaries collected throughout the intervention, which were used to calculate standard behavioral sleep metrics. His sleep efficiency (SE), defined as the amount of time in bed spent asleep, improved from 63% at baseline to 87% by the end of treatment (see Figure 1). Patient Sleep Efficiency. Sleep efficiency is defined as the percentage of time spent sleeping while in bed. The patient’s sleep efficiency has increased over insomnia therapy sessions, from 63% to 87%, indicating good sleep quality near end sessions. To contextualize the case patient’s experience, a qualitative interview was conducted. The interview followed a semi-structured format, allowing for exploration of the patient’s perceptions of treatment, adherence, and symptom changes. This was conducted by a trained member of the research team, and was audio-recorded and transcribed verbatim for identification of recurring themes. This qualitative component was intended to complement the quantitative sleep metrics by providing deeper insight into this patient’s intersectional experience with the intervention. Results dCBT-I Facilitators In addition to demonstrating engagement through treatment completion, the patient also reported enjoying the digital-therapy and continues to complete sleep diaries despite completing treatment. He highlighted the application’s ease of use and comprehensive guidance as facilitators of his successful completion. He cited the app’s ease of use and clear guidance as key facilitators. Although the dCBT-I platform offered closed captions, he was unaware of this feature and instead used Nagish—a mobile app that transforms phone calls into live transcriptions and text into automated voice—which he described as a “game changer,” allowing greater independence and reducing reliance on traditional Relay Services. In the third week of treatment (SE: 44%, Total Sleep Time (TST): 2:27), the patient initiated a coaching session, seeking clarification on sleep diaries. He valued being able to meet with the coach, stating that it “brought comfort and encouraged continuation of the treatment process. “The coaching sessions were conducted over video call, and the patient reported that the range of digital tools enhanced the feasibility of coaching sessions.” When asked how accessibility of the dCBT-I program might be improved for those with hearing disabilities (eg, tailoring the treatment program to individual needs), he responded with the importance of completing the standard treatment in its entirety; “if it was tailored and customized to what [he] ‘thought’ [his] needs were, [he] might have missed some important information along the way.” The patient preferred to utilize personal accessibility tools to complete the treatment, rather than engage in a customized version out of fear that it might remove treatment content. Other facilitators of dCBT-I were its contrasts with in-person insomnia treatment. The patient mentioned feeling disregarded by healthcare providers when seeking insomnia treatment in-person and was met with a primarily medication-based treatment approach. Deaf individuals often face barriers including a lack of culturally competent health care providers, miscommunications between sign language interpreters, and an overall insufficient number of interpreters.16 dCBT-I Barriers A key component of cognitive behavioral insomnia intervention is sleep restriction — encouraging insomnia patients to limit time spent in bed to the reported total sleep time — and is commonly a challenge for patients. The patient reported that sleep restriction was particularly difficult and that aspects of his hearing disability further exacerbated implementation challenges. He noted that, while there were recommendations provided to help patients engage with sleep restriction, some of these recommendations were either inaccessible (eg, use of sound‑based alarms to adhere to the scheduled wake-time, suggestion of music listening to pass time until scheduled bed-time), or had significantly lower feasibility due to his sensory and/or physiological sensitivities (eg, light exposure). That said, he stated that the suggestion of “cognitive shuffling” (eg, repeating the word “the” while attempting sleep) was accessible and useful for him. He described using a silent, internally repeated string of numbers as a means of quieting mental activity, which he found achievable without relying on auditory processing. Similarly, the patient reported cognitive arousal (eg, an active mind, ruminating) due to his deafness; when he closes his eyes, his mind is “always thinking 200 miles an hour.” Interestingly, the patient attributed some of his sleep difficulties to enhanced sensitivity to perceptual changes in the environment, such as slight vibrational and light changes.17 This initially caused difficulty in his adherence to sleep restriction, as he could “sense changes in a room” because of his vigilance of his surroundings. With reduced auditory input, his other senses are heightened, making it difficult for him to stay asleep after onset. As a preliminary finding based on a single-case report, this observation warrants further investigation to determine its broader applicability. He underscored the cultural significance of storytelling in ASL, which fosters connection and understanding through expressive communication. To address these needs, he suggested that integrating deaf-friendly community forums could enhance peer support and accommodate ASL’s narrative style and become more inclusive and effective for the deaf community. The patient’s experience highlighted key accessibility barriers in the dCBT-I platform, notably the absence of features tailored to deaf users, such as closed captioning and real-time chat for questions. Discussion This case study offers insight into the individual barriers faced by differently abled users engaging in dCBT-I, particularly deaf individuals. A key area for improvement is ensuring that content and delivery are fully accessible and address specific needs. While the patient reported positive outcomes, the digital format lacked built-in accommodations, such as clearly aligned and comprehensive closed captioning. This case study is limited by its subjective single-case design, which restricts generalizability to broader deaf or hard-of-hearing populations. These findings should therefore be interpreted as preliminary, warranting confirmation in larger, controlled studies. Nonetheless, combining dCBT-I with telehealth coaching presents a promising, more inclusive model for delivering insomnia treatment across diverse patient populations. An interesting observation in this case relates to the heightened sensitivity of other senses, such as vision and touch, which is reported by individuals with hearing loss. Given that deaf individuals may rely heavily on visual and tactile cues in their environment, it is possible that these heightened senses contribute to sleep disruptions or even circadian misalignment. With this, there is potential for disruptions to the sleep-wake cycle caused by ambient light for deaf individuals with light sensitivity. Further exploration into this observation of the intersection of sensory deprivation within deaf individuals and circadian rhythms would work towards understanding the needs of the deaf community within insomnia treatment. Specific interventions and customizations in dCBT-I programs, such as implementing light therapy, could optimize circadian alignment and work towards a more productive and inclusive digital insomnia treatment. A recurring theme in the patient’s interview responses suggests a desire for normalcy. When asked whether a version of dCBT-I tailored to individual ability would be useful, the patient expressed fear of “missing out” on key treatment aspects. Despite the option of customization, the patient remained firm on wanting to receive all of the information, just as it was presented to others. Further mentions of deaf individuals struggling with loneliness reflect a concern of being “othered” in a treatment setting. Similarly, to foster a connection and find commonalities with the researchers, the patient taught them a few words in ASL. The case study highlights both the potential and the barriers of engaging in dCBT-I as a deaf individual. While dCBT-I can be effective for managing sleep disturbances, the unique needs of deaf individuals—particularly in relation to treatment implementations, access to therapeutic content, and sensory experiences —must be carefully considered. By improving accessibility and promoting inclusivity within digital-health interventions, future dCBT-I programs can better serve this underrepresented population. Conclusion This case offered rare and valuable insight into the experience of a deaf individual engaging in dCBT-I, and the limited access to insomnia treatment in this population. Capturing a patient actively participating in dCBT-I not only elucidated barriers faced by the deaf community but also pinpointed crucial areas for future research and intervention. This study highlights the value in augmenting dCBT-I with relevant tools and technology to increase accessibility to those with hearing disabilities. The patient emphasized the cultural importance of storytelling in ASL, where rich, expressive narratives serve not only as a primary mode of communication but also as a vital tool for learning and connection. These insights point to an opportunity for improving dCBT-I platforms through culturally informed design features. Given the single-case nature of this study, implications regarding specific design features, such as ASL-based storytelling integration, should be understood as directions for future development and investigation. Further, as digital-health interventions continue to expand, this case study highlights the urgent need to design with inclusivity at the forefront. By addressing both technological and cultural barriers, meaningful progress can be made toward equitable mental health care for the deaf and hard-of-hearing communities. Funding Statement This study is funded by the National Heart Lung and Blood Institute (NHLBI) R01HL159180 awarded to Dr. Philip Cheng. Clinical Trial Registration ClinicalTrials.gov ID: NCT05182372 Consort Reporting Guidelines This study was conducted and is reported in accordance with the CONSORT (Consolidated Standards of Reporting Trials) 2010 guidelines. All applicable items from the CONSORT checklist have been addressed to ensure transparency and completeness of reporting. Data Sharing Statement Our data will be made available on reasonable request. Due to ethical, privacy, or security concerns, it will be deidentified. Ethical Statement This study was approved by the Institutional Review Board at Henry Ford Health, under Ethics Approval number [14816]. The study was conducted in accordance with the principles of the Declaration of Helsinki. The clinical trial was registered at ClinicalTrials.gov with identifier [NCT05182372]. The study obtained initial approval on June 3, 2021. Informed Consent Statement Written informed consent was obtained from the patient for publication of this case report, including all accompanying images. The authors have adhered to the CARE (CAse REport) guidelines to ensure that all relevant clinical details are accurately and transparently reported. Author Contributions Veronica Van Rossen: Writing – Original Draft Preparation, Visualization. Ishana Kapoor: Investigation, Writing – Review & Editing. Marleigh Treger: Writing – Review & Editing, Data Curation. Christopher Miller: Data Curation, Writing – Review & Editing. Philip Cheng: Conceptualization, Methodology, Writing – Review & Editing. All authors gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work. Disclosure Christopher Miller is an employee of Big Health Inc., the manufacturer of Sleepio, and discloses holding stock options in the company. The authors declare that they have no known further competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. References Associated Data Data Availability Statement Our data will be made available on reasonable request. Due to ethical, privacy, or security concerns, it will be deidentified.